BLUEJAY DIAGNOSTICS INC (BJDX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$2.19-4.37%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · BJDX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | — | 0.2 | — | — |
| Total Revenues | — | — | — | — | 0.2 | — | — |
| Cost of Revenues | — | — | — | — | 0.2 | — | — |
| Gross Profit | — | — | — | — | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | — | — | 0.3 | 0.5 | — | — |
| R&D Expenses | 3.6 | 3.0 | 3.5 | 5.7 | 4.2 | 1.1 | 0.5 |
| Operating Income | (7.4) | (7.0) | (7.2) | (10.3) | (9.3) | (3.2) | (1.2) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.0 | 0.8 | — | — | 0.0 | — |
| Interest & Investment Income | 0.1 | 0.1 | 0.1 | 0.2 | — | — | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.1 | (0.5) | 0.4 | 0.0 | (0.3) | 0.0 |
| Asset Writedown | — | 0.0 | — | 0.0 | 0.2 | — | — |
| Net Income | |||||||
| Net Income | (7.3) | (6.8) | (7.7) | (10.0) | (9.3) | (3.5) | (1.2) |
| Per Share | |||||||
| Basic EPS | (3.50) | (15.25) | (114.19) | — | (9.22) | (0.41) | — |
| Diluted EPS | (3.50) | (15.25) | (114.19) | — | (9.22) | (0.41) | — |
| Basic Weighted Avg Shares | 2.1 | 0.4 | 0.2 | 0.0 | 1.0 | 8.5 | — |
| Diluted Weighted Avg Shares | 2.1 | 0.4 | 0.2 | 0.0 | 1.0 | 8.5 | — |
| Supplemental | |||||||
| EBITDA | — | — | — | — | (9.2) | (3.1) | (1.0) |
| EBIT | (7.4) | (7.0) | (7.2) | (10.3) | (9.3) | (3.2) | (1.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.